GRANULES Q4 FY26 Earnings Call Transcript & Analysis
Revenue 53656 million (+20% YoY); EBITDA 11851 million (+25% YoY); EBITDA Margin 22.1%. FY26 Revenue reached ₹53,656 million, growing 20% YoY.
Read full transcript & analysis
Every earnings call for GRANULES — management tone, guidance, KPIs and promise tracking, quarter by quarter.
GRANULES · 6 transcripts · Healthcare · latest Q4 FY26Revenue 53656 million (+20% YoY); EBITDA 11851 million (+25% YoY); EBITDA Margin 22.1%. FY26 Revenue reached ₹53,656 million, growing 20% YoY.
Read full transcript & analysisRevenue ₹1,388 cr (+22% YoY); EBITDA ₹308 cr (+34% YoY); EBITDA Margin 22.2% (+2% YoY). Revenue of INR 1,388 crores, up 22% YoY and 7% QoQ.
Read full transcript & analysisRevenue 12101 million (+3% YoY); EBITDA 2467 million (−5% YoY); EBITDA Margin 20.4%. Revenue for Q1 FY26 stood at ₹12,101 million, reflecting a 3% YoY growth and 1% QoQ growth.
Read full transcript & analysisRevenue 11974 million (+2% YoY); EBITDA 2524 million (−1% YoY); EBITDA Margin 21.1% (−1% YoY). Q4 FY25 Revenue stood at ₹11,974 million, marking a 2% YoY growth and 5% QoQ growth.
Read full transcript & analysisRevenue 11377 million (−2% YoY); EBITDA 2303 million (−8% YoY); EBITDA Margin 20.2%. Q3 FY25 Revenue stood at INR 11,377 million, a 2% decline YoY but an 18% increase QoQ.
Read full transcript & analysisRevenue 11799 million (+20% YoY); EBITDA 2593 million (+90% YoY); EBITDA Margin 22.0%. Revenue grew 20% YoY to ₹11,799 million in Q1 FY25.
Read full transcript & analysis